Todd A. Harrison, J.D. is a Partner and Co-Chair of Venable LLP's FDA Group. He works extensively in the areas of food and dietary supplement safety and labeling and advertising claims to help clients in the consumer products, drug and medical device, and dietary products industries comply with government regulations.
FDA recently proposed the most significant changes to its GRAS framework since 1958. For companies managing ingredient compliance, the proposed mandatory filing obligations raise questions about statutory authority, agency capacity, and whether its design matches its stated objectives.
